Nivolumab plus ipilimumab for advanced kidney cancer after progression on immunotherapy
This phase 2 study looked at the effect on survival [...]
This phase 2 study looked at the effect on survival [...]
A recent study looking at a CAR T-cell therapy (called [...]
At the International Kidney Cancer Symposium (IKCS) in the USA [...]
When ipilimumab plus nivolumab or axitinib plus pembrolizumab are used [...]
Yesterday is was announced that the Scottish Medicines Consortium (SMC) [...]
In this phase 3b/4 study, people with advanced kidney cancer [...]
A biomarker is a biological molecule found in blood, other body [...]
Late last week we learnt that the National Institute for [...]
Cell metabolism in kidney cancer tumours is disrupted, and tumour [...]
The phase 2 KEYNOTE-B61 study was presented at the recent [...]